THERE IS NO ASSOCIATION BETWEEN THE –318 (C→T) AND +49 (A→G) CTLA4 GENE POLYMORPHISMS AND THE COELIAC CONDITION IN THE MALTESE POPULATION
Borg J1,*, Scerri CA1,3, Vidal C2, Xuereb Anastasi A1,2
*Corresponding Author: Joseph Borg, B.Sc (Hons) MLS, Laboratory of Molecular Genetics, Department of Physiology and Biochemistry, Biomedical Science Building, University of Malta, Msida, Malta; Tel.: +356-2340-2774, Fax: +356-2134-3535, E-mail: joseph.borg@biotech.um.edu.mt
page: 49

DISCUSSION

Although the pathogenesis of CD is still unknown, there is evidence [4,5] of an association with the major histocompatibility (HLA)-DQ2 and DQ8 that are found on antigen presenting cells enabling the recognition of deami­dated gliadin. The HLA-linked markers contribute about 35% to the genetic predisposition for CD. Thus, other non HLA-linked genes play a major role in the pathogenesis of CD.

      The CTLA4 gene is a candidate gene for the suscepti­bility of T-cell-mediated diseases. Polymorphisms within this gene have been reported in association with a large number of autoimmune diseases, including type I diabetes mellitus, CD, multiple sclerosis and autoimmune thyroid disease [6]. Although the exact pathological polymorphism has not been identified, it has been shown that individuals who carry thymine at position –318 (C→T) of the CTLA4 promoter and individuals who are homozygous for adenine at position +49 (A→G) in exon 1, have significantly increased expression of CTLA4 mRNA and cell-surface CTLA4. As documented in various other studies [7,8], the C allele in the –318 (C→T) locus is in linkage disequilib­rium with the A allele in the +49 (A→G) locus, indicating that the initial allele framework was one of C at the –318 locus and an A at the +49 locus.

      In both of our coeliac and control groups, the alleles for both polymorphisms were in Hardy-Weinberg equilib­rium. In addition, no association was found between the single alleles and CD and between haplotypes and CD. This contrasts with results reported in some studies con­ducted on Italian, English and Scandinavian countries [9-14] where a positive association was found between the A allele at the +49 (A→G) polymorphism, while it is in agreement with two other studies done on Italian and Tuni­sian coeliac patients [15] and North American coeliac patients [16]. In a recent study [8] on various European populations, the association between the +49 A allele and CD was identified only in the Norwegian/Swedish popula­tions. In the same study, the –318 T polymorphism was associated with CD, again only in Norwegian/Swedish populations.

      These differences in results among different European populations could be explained either by statistical anom­alies arising from small sample size or because the caus­ative polymorphism is linked to CTLA4 polymorphism in some populations but not in others, or because of different pathophysiological causes for CD. Our results indicate that the Maltese population is genetically nearer to the Italian and Tunisian than to the Northern European populations. This closeness to the Italian population has been shown in a Mediterranean study on the Y-chromosome [17]. In con­trast, our results could be due to founder effects present in the Maltese population which could result in a different pathogenesis for this condition in this population. This has been effectively shown in single gene disorders for which a single mutation is predominant and was not common in the Mediterranean Basin [18-20]. The Maltese population numbered about 17,000 in 1530 AD, and gradually increased to reach about 100,000 by 1800 AD. Demo­graphic data of the Maltese Islands for this period show that the increase was not due to immigration [21]. Thus, hypotheses that within this population there exists a founder effect for CD is also plausible.

 




Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006